Kassar, Mohammad; Praz, Fabien; Hunziker, Lukas; Pilgrim, Thomas; Windecker, Stephan; Seiler, Christian; Brugger, Nicolas (2022). Anatomical and Technical Predictors of Three-Dimensional Mitral Valve Area Reduction After Transcatheter Edge-To-Edge Repair. Journal of the American Society of Echocardiography, 35(1), pp. 96-104. Elsevier 10.1016/j.echo.2021.08.021
Text
1-s2.0-S0894731721007008-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) |
BACKGROUND
Among current transcatheter therapies for the treatment of mitral regurgitation, the MitraClip (MC; Abbott Vascular, Abbott Park, IL) system is the most commonly used. MitraClip implantation is usually contraindicated in patients with a mitral valve area (MVA) < 4.0 cm2. However, little is known about the real impact of MC implantation on MVA. Our goal was to investigate the factors influencing MVA reduction and derive the minimal MVA required to prevent the development of a clinically significant mitral stenosis (MVA < 1.5 cm2) in different clinical scenarios.
METHODS
Using three-dimensional data sets, the annulus and leaflet anatomy and MVA before clip implantation (MVABC) were assessed. After each MC implant (NTR or XTR), the relative MVA reduction and the absolute residual MVA were measured and their predictors evaluated.
RESULTS
The present analysis included 116 patients. An MC XTR was the first device implanted in 50% of the subjects, and 53% were treated with a single implant. The MVA reduction following one XTR was 57% ± 7% versus 52% ± 8% after one NTR (P = .001). A lower MVA reduction was observed when the MC was placed commissural/central versus paracentral (50% ± 8% vs 57% ± 7%, P < .0001). After a second device, the additional MVA reduction was higher when creating a triple-compared with a double-orifice morphology (34% ± 11% vs 25% ± 9%, P = .001). The MVA after one MC correlated with MVABC as well as with the clip type and position (r = 0.91, P < .0001). The MVABC, orifice morphology, and first device position predicted MVA after two implants (r = 0.82, P < .0001). Based on the mathematical relationship between these parameters, the minimal MVABC needed in eight different clinical scenarios was summarized in a decision algorithm: the values ranged from 3.5 to 4.7 cm2 for one and 4.5 to 6.3 cm2 for two MC strategies.
CONCLUSIONS
The minimal native MVA preventing clinically relevant MS after transcatheter edge-to-edge repair is predicted by the number and location of clip(s), orifice morphology, and device type. Based on these parameters, an algorithm has been derived to optimize patient selection and preprocedural planning.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Kassar, Mohammad, Praz, Fabien Daniel, Hunziker Munsch, Lukas Christoph, Pilgrim, Thomas, Windecker, Stephan, Seiler, Christian, Brugger, Nicolas Jacques |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0894-7317 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Nadia Biscozzo |
Date Deposited: |
20 Jan 2022 09:11 |
Last Modified: |
05 Dec 2022 15:59 |
Publisher DOI: |
10.1016/j.echo.2021.08.021 |
PubMed ID: |
34506920 |
Uncontrolled Keywords: |
Latrogenic mitral stenosis MitraClip Mitral valve area Three-dimensional echocardiography Transcatheter edge-to-edge repair |
BORIS DOI: |
10.48350/163187 |
URI: |
https://boris.unibe.ch/id/eprint/163187 |